Kalbe Farma (KLBF), the largest pharmaceutical firm listed on Indonesia Stock Exchange (IDX), booked net profit of Rp1.92 trillion last year, grew by 10.7% from 2012 as sales revenue increased by 17%, while gross profit also improved 17.5%. Kalbe is now among the most ‘valuable’ stock on IDX, traded eight times equity. How about others?

To subscribe please click here